Reposted by Gabriel Ortega
Excited to announce that our technology has passed an important milestone on its journey towards the clinic. Breakthrough device designation is intended to accelerate the development, assessment, and review of potentially life-saving technologies for which no approved or cleared alternative exists.
linkedin.com
Nutromics Receives FDA Breakthrough Designation for Vancomycin TDM Patch | Nutromics posted on the topic | LinkedIn
Nutromics has been granted FDA Breakthrough Device Designation for our first product in development: a wearable patch for vancomycin therapeutic drug monitoring.
The FDA's Breakthrough Device Progra...